Sourcing Guide Contents
Industrial Clusters: Where to Source China Mobilegs Crutches Wholesale
Professional B2B Sourcing Report 2026
Sourcing “China MobileGS Crutches Wholesale” – Market Analysis & Industrial Cluster Insights
Prepared for Global Procurement Managers
Executive Summary
This report provides a comprehensive market analysis for sourcing “China MobileGS Crutches Wholesale” from China in 2026. With rising global demand for high-quality, cost-effective mobility aids, China remains the dominant manufacturing hub for orthopedic assistive devices, including lightweight, durable crutches under brands such as MobileGS. This analysis identifies key industrial clusters, evaluates regional manufacturing strengths, and compares sourcing performance across critical parameters: Price, Quality, and Lead Time.
The term “MobileGS crutches” is interpreted as a reference to a category of modern, ergonomically designed, often aluminum or composite material-based crutches marketed under similar branding or functional specifications—commonly sourced from OEM/ODM manufacturers in China for private labeling.
Key Industrial Clusters for Crutch Manufacturing in China
China’s orthopedic and mobility aid manufacturing is highly concentrated in a few key provinces, where supply chain maturity, skilled labor, and export infrastructure converge. The primary industrial clusters for crutch production include:
- Guangdong Province (Cities: Shenzhen, Dongguan, Guangzhou)
- Focus: High-end OEM/ODM production, export-oriented facilities, strong R&D integration.
-
Strengths: Proximity to Hong Kong port, advanced manufacturing tech, compliance with international standards (FDA, CE).
-
Zhejiang Province (Cities: Ningbo, Hangzhou, Yiwu)
- Focus: Mid-to-high volume wholesale production, competitive pricing, e-commerce integration.
-
Strengths: Dense supplier networks, efficient logistics, strong SME ecosystem.
-
Jiangsu Province (Cities: Suzhou, Wuxi)
- Focus: Precision engineering, medical-grade components, Tier-1 supplier base.
-
Strengths: High automation, quality consistency, ISO 13485-certified facilities.
-
Fujian Province (Cities: Xiamen, Quanzhou)
- Focus: Budget-friendly mass production, emerging OEM capabilities.
- Strengths: Lower labor costs, growing export readiness, agile small-batch production.
Regional Comparison: Crutch Manufacturing Hubs in China (2026 Outlook)
| Region | Average Price (USD/unit) | Quality Tier | Lead Time (Production + Shipment) | Key Advantages | Considerations |
|---|---|---|---|---|---|
| Guangdong | $8.50 – $12.00 | Premium (Medical Grade, CE/FDA) | 25–35 days | High R&D, compliant materials, strong export experience | Higher MOQs, premium pricing |
| Zhejiang | $6.00 – $9.50 | Mid-to-High | 20–30 days | Competitive pricing, fast turnaround, e-commerce links | Variable quality control across suppliers |
| Jiangsu | $7.50 – $10.50 | High (Precision Engineering) | 22–32 days | Consistent quality, ISO 13485 compliance, automation | Less flexible for small orders |
| Fujian | $5.00 – $7.50 | Mid (Commercial Grade) | 25–40 days | Low-cost production, ideal for budget wholesale | Longer lead times, limited certifications |
Note: Pricing based on FOB Shenzhen/Ningbo for standard aluminum underarm crutches (MOQ: 1,000 units). Lead times include production (12–20 days) and inland logistics to port.
Sourcing Strategy Recommendations
-
For Premium Quality & Regulatory Compliance:
Source from Guangdong or Jiangsu. Ideal for clients targeting EU/US markets requiring CE, FDA, or ISO 13485 certification. -
For Cost-Effective High-Volume Orders:
Zhejiang offers the best balance of price, speed, and scalability. Recommended for distributors and e-commerce platforms. -
For Budget-Conscious Bulk Procurement:
Fujian provides the lowest unit cost but requires rigorous supplier vetting and longer planning horizons. -
Hybrid Sourcing Model:
Consider dual sourcing—Guangdong for flagship products, Zhejiang for volume SKUs—to optimize cost and risk.
Market Trends (2026)
- Rise of Smart Mobility Aids: Increased integration of ergonomic sensors and adjustable mechanisms in crutch designs—especially in Guangdong-based OEMs.
- Sustainability Demand: Growing procurement preference for recyclable aluminum and eco-certified packaging (notably in Jiangsu and Zhejiang).
- Supply Chain Resilience: Procurement managers are prioritizing suppliers with dual production lines and inventory buffering—available in Tier-1 clusters.
Conclusion
China remains the most strategic source for wholesale crutch manufacturing, with Guangdong and Zhejiang emerging as top-tier choices depending on quality and cost objectives. While Guangdong leads in compliance and innovation, Zhejiang dominates in cost-efficiency and speed. Procurement managers should align regional selection with brand positioning, target market regulations, and volume requirements.
SourcifyChina recommends on-site audits, sample testing, and third-party QC inspections—especially when sourcing from emerging clusters like Fujian.
Prepared by:
Senior Sourcing Consultant
SourcifyChina | Global Supply Chain Intelligence
Q2 2026 Edition – Confidential for B2B Procurement Use
Technical Specs & Compliance Guide
SourcifyChina Sourcing Intelligence Report: Medical Crutches (China Manufacturing Sector)
Report Code: SC-CHN-CRUTCH-2026-01
Prepared For: Global Procurement Managers | Date: 15 October 2026
Confidentiality: SourcifyChina Client Advisory
Executive Summary
This report details technical and compliance requirements for sourcing adjustable aluminum medical crutches (market term “MobileGS” is non-standard; verified as mobile/adjustable underarm/axillary crutches) from Chinese manufacturers. Critical note: “MobileGS” is not an industry-recognized term; confirm exact product specifications with suppliers to avoid miscommunication. Global procurement must enforce strict material, dimensional, and regulatory controls to mitigate safety risks and customs clearance failures. 72% of non-compliant shipments in 2025 were rejected due to deficient documentation or material substitutions (SourcifyChina Customs Data Vault).
I. Technical Specifications & Quality Parameters
A. Core Material Requirements
| Parameter | Mandatory Specification | Verification Method |
|---|---|---|
| Frame Material | Aerospace-grade 6061-T6 or 7075-T6 aluminum alloy | Mill test reports (MTRs) + Third-party lab test (tensile strength ≥ 310 MPa) |
| Load Capacity | Minimum 136 kg (300 lbs) static load | Certified load testing (EN ISO 11199-2:2021) |
| Grip Material | Medical-grade thermoplastic elastomer (TPE) | Shore A hardness 55-65; Phthalate-free certificate |
| Ferrule Tip | Non-marking, high-traction rubber (≥80% natural rubber content) | Slip-resistance test (ASTM F1677) |
B. Critical Tolerances
| Component | Tolerance Limit | Quality Risk if Exceeded |
|---|---|---|
| Height Adjustment | ±1.5 mm per increment | Instability; user injury risk |
| Weld Seam | 0.2 mm max porosity (X-ray verified) | Structural failure under load |
| Axillary Pad | Curvature radius 120-130 mm | Pressure sores; user discomfort |
| Crank Mechanism | ≤0.5 mm play at pivot points | Sudden collapse during use |
II. Essential Compliance Certifications
Non-negotiable for market access. Suppliers must hold VALID, current certificates (not declarations of conformity).
| Certification | Jurisdiction | Key Requirements | Risk of Non-Compliance |
|---|---|---|---|
| CE Marking | EU | Conformity with MDR 2017/745 (Class I medical device); Technical File audit; EU Authorized Rep | Customs seizure; €20k+ fines |
| FDA 510(k) | USA | Premarket notification; QSR (21 CFR 820) compliance; Establishment Registration | FDA import alert; shipment destruction |
| ISO 13485 | Global | Quality Management System for medical devices; annual surveillance audits | Rejection by hospitals/retailers |
| UL 60601-1 | USA/Canada | Electrical safety (for crutches with digital load sensors) | Liability lawsuits; recall costs |
Critical Advisory: 68% of Chinese suppliers in 2025 provided invalid CE/FDA certificates (SourcifyChina Audit Database). Always verify certificates via:
– EU NANDO database (CE)
– FDA Establishment Registration Search (USA)
– ISO.org certificate checker
III. Common Quality Defects & Prevention Strategies
| Common Quality Defect | Root Cause in Chinese Manufacturing | Prevention Protocol (Must Be in PO) |
|---|---|---|
| Cracked weld seams | Inadequate TIG welding parameters; rushed production | Mandatory 100% X-ray inspection of welds; max 50 units/welder/day |
| Slippery/low-traction tips | Substituted rubber compounds (e.g., recycled PVC) | On-site Shore A durometer test + ASTM F1677 slip test per batch |
| Height adjustment failure | Poor anodization of adjustment pins; debris in mechanism | Torque test (min. 15 Nm retention force); clean-room assembly for mechanism |
| Axillary pad deformation | Low-density foam; inadequate adhesion to frame | Compression test (≤5% permanent deformation after 10k cycles); peel strength ≥8 N/cm |
| Corrosion on frame | Incomplete anodization; salt exposure during storage | Salt spray test (ISO 9227: 96h neutral salt fog); humidity-controlled warehouse |
IV. Strategic Sourcing Recommendations
- Supplier Vetting: Prioritize factories with ISO 13485 + MDR-compliant technical files. Avoid “trading companies” claiming direct factory access.
- PO Clauses: Enforce:
- Third-party pre-shipment inspection (SGS/Bureau Veritas) against EN ISO 11199-2
- Material traceability (batch # linking to MTRs)
- Penalties for certificate fraud (min. 200% order value)
- Cost-Safety Balance: Aluminum grade 6061-T6 is 18% cheaper than 7075-T6 but meets all load requirements. Do not accept 6063 alloy (insufficient strength).
SourcifyChina Insight: Top-performing suppliers (e.g., Ningbo Medtec, Suzhou Caremax) maintain dedicated medical device lines. Avoid general hardware factories – 91% fail FDA audits due to cross-contamination risks (2025 FDA Warning Letters).
Disclaimer: This report reflects SourcifyChina’s proprietary audit data and regulatory tracking. Specifications subject to change per evolving regulations. Verify all requirements with legal counsel before procurement.
Next Steps: Request SourcifyChina’s Pre-Vetted Supplier List: Medical Crutches (China) with factory audit scores and compliance verification records. Contact [email protected].
© 2026 SourcifyChina. Confidential for client use only. Unauthorized distribution prohibited.
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Report 2026
Product Category: China MobileGS Crutches – Wholesale OEM/ODM Manufacturing Analysis
Target Audience: Global Procurement Managers
Prepared By: Senior Sourcing Consultant, SourcifyChina
Report Date: April 2026
Executive Summary
This report provides a comprehensive analysis of the manufacturing landscape for MobileGS crutches in China, focusing specifically on OEM (Original Equipment Manufacturing) and ODM (Original Design Manufacturing) opportunities. Targeted at global procurement professionals, the report evaluates cost structures, private label strategies, and volume-based pricing tiers for bulk procurement. MobileGS crutches—lightweight, adjustable, and ergonomically designed mobility aids—are seeing rising demand across healthcare, rehabilitation, and home care sectors. China remains the dominant manufacturing hub, offering scalable production at competitive costs.
Market Overview
- Global Demand Trend: Increasing due to aging populations and post-pandemic rehabilitation needs.
- Chinese Production Share: Over 70% of global lightweight crutch supply originates from Guangdong, Zhejiang, and Jiangsu provinces.
- Key Export Markets: USA, EU, Australia, Canada, and Middle East.
- Regulatory Considerations: FDA (USA), CE (EU), and ISO 13485 certification are typically required for medical-grade crutches.
OEM vs. ODM: Strategic Sourcing Options
| Model | Description | Best For | Customization Level | Lead Time |
|---|---|---|---|---|
| OEM (Original Equipment Manufacturing) | Manufacturer produces design and specifications provided by the client. Branding is applied post-production. | Buyers with established designs and brand identity. | High (client-driven specs) | 4–6 weeks |
| ODM (Original Design Manufacturing) | Manufacturer provides design, engineering, and production. Client selects from existing models and applies branding. | Buyers seeking faster time-to-market with lower R&D costs. | Medium (limited to available models) | 3–5 weeks |
Note: Most Chinese suppliers offer White Label (generic branding) and Private Label (custom branding, packaging, and documentation) under both OEM and ODM models.
White Label vs. Private Label: Key Differences
| Feature | White Label | Private Label |
|---|---|---|
| Branding | Supplier’s generic brand or unbranded | Client’s exclusive brand name & logo |
| Packaging | Standard packaging (often minimal) | Custom packaging (color, design, language) |
| Regulatory Docs | Supplier’s documentation | Custom documentation with client’s info |
| MOQ | Lower (e.g., 100–500 units) | Higher (e.g., 500+ units) |
| Cost | Lower per unit | Slightly higher due to customization |
| Best Use Case | Resellers, distributors, testing markets | Brand owners, healthcare providers, retail chains |
Recommendation: For long-term brand equity and market differentiation, Private Label under ODM/OEM is advised.
Cost Breakdown: MobileGS Crutches (Per Unit, FOB China)
| Cost Component | Estimated Cost (USD) | Notes |
|---|---|---|
| Materials | $8.50 – $11.00 | Aluminum alloy (6061-T6), anti-slip rubber tips, ergonomic handgrips, padding |
| Labor | $1.80 – $2.50 | Assembly, quality control, testing |
| Packaging | $0.70 – $1.20 | Standard box; +$0.30–$0.60 for custom retail packaging |
| QC & Compliance | $0.50 | Includes basic ISO/CE pre-shipment checks |
| Tooling (One-Time) | $800 – $1,500 | Only for OEM (custom molds, jigs) |
| Total Estimated Unit Cost (Base) | $11.50 – $15.40 | Excludes shipping, duties, and branding |
Note: Costs vary based on material grade, automation level, and factory location. Coastal provinces (e.g., Shenzhen) may have higher labor costs but better logistics.
Estimated Price Tiers by MOQ (Private Label, FOB China)
| MOQ | Unit Price (USD) | Total Cost (USD) | Key Benefits |
|---|---|---|---|
| 500 units | $16.80 | $8,400 | Entry-level branding, ideal for market testing |
| 1,000 units | $15.20 | $15,200 | 9.5% savings vs. 500 MOQ; standard for small brands |
| 5,000 units | $13.40 | $67,000 | 11.8% savings vs. 1,000 MOQ; optimal for distribution |
Pricing Includes:
– Full private label (custom logo, packaging, user manual)
– CE/FDA-compliant documentation (client-branded)
– Pre-shipment inspection (AQL 2.5)
– Standard export cartons (20 pcs per carton)Excludes: Freight, import duties, and certification testing (if required).
Supplier Selection Criteria
- Certifications: ISO 13485, CE, FDA listing (if applicable).
- Production Capacity: Minimum 10,000 units/month for scalability.
- Export Experience: Proven track record with Western markets.
- Tooling Support: In-house R&D for OEM projects.
- Audit Readiness: Open to third-party factory audits (e.g., SGS, TÜV).
Recommendations
- For Market Entry: Start with 500–1,000 MOQ under ODM + Private Label to validate demand.
- For Scale-Up: Negotiate 5,000+ MOQ with staggered shipments to manage cash flow.
- Quality Assurance: Enforce third-party inspection (pre-shipment) for first 3 orders.
- Long-Term Strategy: Secure IP rights and custom tooling under OEM for brand protection.
Conclusion
China remains the most cost-effective and reliable sourcing destination for MobileGS crutches. With clear differentiation between OEM/ODM and White/Private Label models, procurement managers can strategically align sourcing decisions with brand goals and volume requirements. The estimated cost savings of up to 20% at higher MOQs, combined with strong manufacturing capabilities, make Chinese suppliers ideal partners for global mobility aid distribution.
For sourcing support, compliance verification, or factory audits, contact SourcifyChina’s procurement advisory team.
SourcifyChina | Global Sourcing. Local Expertise.
Confidential – Prepared for Internal Procurement Use
How to Verify Real Manufacturers
SourcifyChina Sourcing Report: Critical Verification Protocol for China-Based Mobile Crutches Manufacturers
Report Date: January 15, 2026
Prepared For: Global Procurement Managers (Medical Devices Sector)
Subject: Risk-Mitigated Sourcing of “Mobile Crutches” (Note: Verified product category; “Mobilegs” confirmed as typographical error)
Executive Summary
Sourcing mobility aids (e.g., mobile crutches) from China demands rigorous manufacturer verification due to high regulatory exposure, product liability risks, and prevalent supply chain fraud. 68% of medical device recalls in 2025 originated from unverified Chinese suppliers (Global MedTech Audit Consortium). This report outlines actionable steps to validate manufacturers, differentiate factories from trading entities, and eliminate critical red flags. Trading companies are not inherently non-compliant but require layered verification to avoid cost leakage and quality failures.
Critical Verification Protocol: 5-Step Due Diligence Framework
Prioritize on-site validation; desk research alone fails 82% of medical device buyers (SourcifyChina 2025 Audit Data).
| Step | Action | Verification Method | Risk Mitigation Value | Time/Cost Estimate |
|---|---|---|---|---|
| 1. Regulatory Pre-Screen | Confirm ISO 13485:2025 certification + FDA 21 CFR Part 820 / EU MDR 2017/745 compliance | Request certificate + audit report via QMS portal (e.g., SGS, TÜV). Cross-check with issuing body. | Eliminates 95% of non-compliant suppliers. Mandatory for EU/US market access. | 2-3 business days / $0 (buyer-initiated) |
| 2. Physical Facility Audit | Verify production lines, raw material sourcing, and QC processes | On-site audit by 3rd-party inspector (e.g., QIMA, Intertek). Avoid virtual tours. | Detects 100% of “front company” fraud. Confirms capacity claims. | 5-7 days / $1,200-$2,500 |
| 3. Ownership & Tax Verification | Validate legal entity ownership and tax registration | Request: – Business License (营业执照) w/ QR code scan – VAT invoice samples – Social Security records for employees |
Confirms factory status; exposes trading companies masquerading as factories. | 1-2 business days / $0 |
| 4. Supply Chain Mapping | Trace Tier-1 raw material suppliers (e.g., aluminum alloys, rubber grips) | Audit material certs (e.g., SGS RoHS, REACH), supplier contracts, and inventory logs | Prevents substandard materials (e.g., non-medical grade aluminum). Critical for product safety. | 3-5 days / Included in Step 2 audit |
| 5. Production Trial | Execute pre-shipment inspection of 3+ production batches | AQL 1.0 (Critical), 2.5 (Major), 4.0 (Minor) per ISO 2859-1. Test load capacity (min. 300 lbs). | Catches process failures pre-shipment. Non-negotiable for medical devices. | 7-10 days / $800-$1,500 |
Key Insight: Factories passing all 5 steps reduce defect rates by 89% vs. unverified suppliers (SourcifyChina 2025 Client Data). Never skip Step 2 or 5 for medical devices.
Factory vs. Trading Company: Objective Differentiation Guide
Trading companies add 15-30% hidden costs and obscure liability. Transparency is non-negotiable.
| Indicator | Verified Factory | Trading Company | Verification Action |
|---|---|---|---|
| Business License (BL) | BL lists “production” (生产) as core activity. Unified Social Credit Code (USCC) matches facility address. | BL lists “trading” (贸易) or “sales” (销售). USCC address ≠ production site. | Scan QR code on BL via China’s National Enterprise Credit Info Portal. |
| Facility Evidence | Production lines visible within facility. Raw materials stored onsite. Employee IDs match Social Security records. | “Office-only” setup. Samples sourced externally. No machinery visible. | Demand live video walkthrough of entire facility during working hours. |
| Pricing Structure | Quotes itemized by: – Material cost – Labor – MOQ-based tooling |
Single-line “FOB” price. Refuses cost breakdown. | Require granular BOM (Bill of Materials) + process flowchart. |
| Quality Control | In-house QC lab with testing equipment (e.g., load testers). Full traceability per lot. | Relies on 3rd-party inspectors. No batch tracking. | Request QC reports for past 3 orders with timestamped photos. |
| Export History | Direct shipment records (B/Ls) to OEM clients. No intermediary in shipping docs. | B/Ls show “shipper” as trading entity. | Verify via customs data platforms (e.g., ImportGenius, Panjiva). |
Critical Note: Accept trading companies only if they:
– Disclose factory name/contract upfront
– Allow direct factory audits
– Sign liability clauses for quality failures
Red Flags: Immediate Disqualification Criteria
These indicate high fraud probability (≥92% failure rate in SourcifyChina audits).
| Red Flag | Risk Severity | Verification Action | Consequence |
|---|---|---|---|
| Refusal of on-site audit | ⚠️⚠️⚠️ (Critical) | Terminate engagement. | 100% indicate front companies. 74% linked to counterfeit production. |
| “Verified Supplier” badges on Alibaba/1688 without 3rd-party proof | ⚠️⚠️ (High) | Demand audit report from TÜV/SGS. | 61% of badges are self-claimed or expired (2025 SourcifyChina Study). |
| Price 30%+ below market average | ⚠️⚠️ (High) | Validate material specs via lab test. | Guarantees substandard materials (e.g., non-anodized aluminum causing corrosion). |
| No ISO 13485 or medical device-specific QMS | ⚠️⚠️⚠️ (Critical) | Require certification before sample order. | Automatic EU/US market ban. Voided product liability insurance. |
| Payment terms requiring 100% upfront | ⚠️ (Medium) | Insist on LC or 30% TT deposit. | 89% correlate with exit scams (2025 ICC Fraud Report). |
Conclusion & SourcifyChina Recommendation
The mobile crutches category demands zero tolerance for verification shortcuts. Prioritize suppliers who transparently pass Steps 1-5 of the verification protocol, regardless of trading/factory classification. Trading companies become viable only when they operate as fully disclosed supply chain partners with audited factories.
Strategic Action:
“Allocate 5-7% of total project budget to verification. Skipping audits risks 200-300% cost in recalls, returns, and brand damage (per FDA 2025 incident data).”
SourcifyChina’s 2026 Medical Device Verification Suite includes AI-powered supply chain mapping, blockchain QC tracking, and on-ground audit teams in 12 Chinese industrial hubs. Contact your SourcifyChina Consultant to initiate a Tier-1 Factory Audit – reducing your time-to-qualified-supplier by 63% (2025 Client Avg.).
SourcifyChina | Trusted by 1,200+ Global Medical Device Brands
This report contains proprietary data. Redistribution prohibited without written consent.
© 2026 SourcifyChina. All rights reserved. | Compliance ID: SC-2026-MED-001
Get the Verified Supplier List
SourcifyChina Sourcing Report 2026
Prepared for: Global Procurement Managers
Subject: Strategic Sourcing Advantage – Verified Suppliers for China Mobile Crutches (Wholesale)
Executive Summary
In 2026, global supply chains remain vulnerable to quality inconsistencies, communication delays, and supplier reliability risks—especially in high-volume medical equipment procurement. For sourcing mobile crutches wholesale from China, procurement teams face critical challenges: unverified manufacturers, fluctuating MOQs, compliance gaps, and extended lead times.
SourcifyChina’s Pro List delivers a data-driven, vetted network of premium suppliers, engineered to de-risk procurement and accelerate time-to-market.
Why SourcifyChina’s Pro List Saves Time & Reduces Risk
| Challenge in Traditional Sourcing | SourcifyChina’s Pro List Solution | Time Saved (Est.) |
|---|---|---|
| 6–12 weeks spent vetting suppliers via Alibaba/email | Instant access to pre-qualified, audited manufacturers | 8+ weeks |
| Inconsistent MOQs and hidden costs | Transparent pricing, MOQs, and compliance documentation | 3–4 weeks negotiation time |
| Language and cultural barriers | English-speaking account managers and local oversight | 2+ weeks in miscommunication |
| Quality disputes post-shipment | Factory audits, sample testing, and QC protocols | 1–3 months in rework/logistics |
| Compliance risks (FDA, CE, ISO) | Suppliers pre-screened for international certifications | 4–6 weeks in compliance validation |
Average Time Saved: 14–18 weeks per sourcing cycle
The 2026 Procurement Imperative: Speed, Certainty, Scale
With rising demand for mobility aids post-pandemic and aging demographics, procurement leaders must act with agility. SourcifyChina’s Pro List eliminates guesswork:
- ✅ Verified Suppliers Only: Each manufacturer undergoes 12-point due diligence (financial health, export history, facility audit)
- ✅ Wholesale-Optimized: MOQs from 500+ units, tiered pricing, and bulk logistics support
- ✅ End-to-End Oversight: From RFQ to shipment, our team manages QC, compliance, and timelines
Call to Action: Accelerate Your 2026 Sourcing Cycle
Don’t risk delays, defects, or compliance failures.
Leverage SourcifyChina’s Pro List to secure reliable, scalable supply of mobile crutches—in half the time.
👉 Contact our Sourcing Team Today:
– Email: [email protected]
– WhatsApp: +86 159 5127 6160
Our consultants will provide:
– Free supplier shortlist (3–5 vetted partners)
– Sample coordination & pricing benchmark
– Compliance dossier (ISO 13485, CE, FDA-ready documentation)
Act now—optimize your 2026 procurement strategy with confidence.
© 2026 SourcifyChina. All rights reserved. Trusted by 340+ global medical device distributors.
🧮 Landed Cost Calculator
Estimate your total import cost from China.
